Lenalidomide/Dexamethasone as Salvage Treatment in Mantle-Cell Lymphoma (MCL)


Lenalidomide/Dexamethasone as Salvage Treatment in Mantle-Cell Lymphoma (MCL)
Slides from a presentation at ASH 2010 and transcribed comments from a recent interview with Bruce D Cheson, MD (12/23/10)

Zaja F et al. Salvage treatment with lenalidomide and dexamethasone in patients with relapsed or refractory mantle cell lymphoma: Clinical results and modifications of angiogenic biomarkers. Proc ASH 2010;Abstract 966.

Dr Cheson is Professor of Medicine, Head of Hematology and Director of Hematology Research at Georgetown University Hospital’s Lombardi Comprehensive Cancer Center in Washington, DC.